[go: up one dir, main page]

SE0001208D0 - Novel compounds - Google Patents

Novel compounds

Info

Publication number
SE0001208D0
SE0001208D0 SE0001208A SE0001208A SE0001208D0 SE 0001208 D0 SE0001208 D0 SE 0001208D0 SE 0001208 A SE0001208 A SE 0001208A SE 0001208 A SE0001208 A SE 0001208A SE 0001208 D0 SE0001208 D0 SE 0001208D0
Authority
SE
Sweden
Prior art keywords
ring
phenyl
novel compounds
compounds
heteroaromatic ring
Prior art date
Application number
SE0001208A
Other languages
English (en)
Swedish (sv)
Inventor
William Brown
Christopher Walpole
Original Assignee
Astrazeneca Canada Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Canada Inc filed Critical Astrazeneca Canada Inc
Priority to SE0001208A priority Critical patent/SE0001208D0/xx
Publication of SE0001208D0 publication Critical patent/SE0001208D0/xx
Priority to ARP010101478A priority patent/AR029823A1/es
Priority to ES01918114T priority patent/ES2236203T3/es
Priority to RU2002125506/04A priority patent/RU2002125506A/ru
Priority to AU4498201A priority patent/AU4498201A/xx
Priority to BR0109817-9A priority patent/BR0109817A/pt
Priority to CA002403600A priority patent/CA2403600A1/en
Priority to EEP200200577A priority patent/EE200200577A/xx
Priority to PT01918114T priority patent/PT1286986E/pt
Priority to SI200130327T priority patent/SI1286986T1/xx
Priority to SK1424-2002A priority patent/SK285076B6/sk
Priority to CZ20023288A priority patent/CZ20023288A3/cs
Priority to NZ522143A priority patent/NZ522143A/en
Priority to IL15189101A priority patent/IL151891A0/xx
Priority to HU0300402A priority patent/HUP0300402A3/hu
Priority to US10/240,114 priority patent/US6753335B2/en
Priority to EP01918114A priority patent/EP1286986B1/de
Priority to PL01357770A priority patent/PL357770A1/xx
Priority to JP2001572496A priority patent/JP2003529598A/ja
Priority to CNB018104231A priority patent/CN1182134C/zh
Priority to DK01918114T priority patent/DK1286986T3/da
Priority to AT01918114T priority patent/ATE289603T1/de
Priority to PCT/SE2001/000708 priority patent/WO2001074806A1/en
Priority to DE60109032T priority patent/DE60109032T2/de
Priority to MXPA02009759A priority patent/MXPA02009759A/es
Priority to KR1020027013208A priority patent/KR100755153B1/ko
Priority to AU2001244982A priority patent/AU2001244982B2/en
Priority to IS6574A priority patent/IS6574A/is
Priority to ZA200207973A priority patent/ZA200207973B/en
Priority to NO20024777A priority patent/NO323466B1/no
Priority to HK03104019A priority patent/HK1051692A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Addiction (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pulmonology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Anesthesiology (AREA)
  • Toxicology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
SE0001208A 2000-04-04 2000-04-04 Novel compounds SE0001208D0 (sv)

Priority Applications (31)

Application Number Priority Date Filing Date Title
SE0001208A SE0001208D0 (sv) 2000-04-04 2000-04-04 Novel compounds
ARP010101478A AR029823A1 (es) 2000-04-04 2001-03-28 Derivados de quinolinil-piperidin-4-iliden-metil-benzamida, proceso para su preparacion, intermediarios utiles en ese proceso, usos de los mismos y composicion farmaceutica
AU2001244982A AU2001244982B2 (en) 2000-04-04 2001-03-30 Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain
HU0300402A HUP0300402A3 (en) 2000-04-04 2001-03-30 Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain and pharmaceutical compositions containing them
PL01357770A PL357770A1 (en) 2000-04-04 2001-03-30 Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain
AU4498201A AU4498201A (en) 2000-04-04 2001-03-30 Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment ofpain
BR0109817-9A BR0109817A (pt) 2000-04-04 2001-03-30 Composto, processo para preparar o mesmo, uso de um composto, composição farmacêutica, e, métodos para o tratamento da dor, para o tratamento de distúrbios gastrointestinais, e para o tratamento de lesões espinhais
CA002403600A CA2403600A1 (en) 2000-04-04 2001-03-30 Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain
EEP200200577A EE200200577A (et) 2000-04-04 2001-03-30 Kinolinüülpiperidiin-4-ülideenmetüülbensamiidi derivaadid valu raviks
PT01918114T PT1286986E (pt) 2000-04-04 2001-03-30 Derivados de quinolil-piperidin-4-ilideno-metil-benzamida para o tratamento da dor
SI200130327T SI1286986T1 (de) 2000-04-04 2001-03-30
SK1424-2002A SK285076B6 (sk) 2000-04-04 2001-03-30 Chinolinylpiperidin-4-ylidénmetylbenzamidové deriváty, ich použitie a farmaceutické kompozície s ich obsahom
CZ20023288A CZ20023288A3 (cs) 2000-04-04 2001-03-30 Deriváty chinolinylpiperidin-4-ylidenmethylbenzamidu pro léčbu bolesti
NZ522143A NZ522143A (en) 2000-04-04 2001-03-30 Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain
IL15189101A IL151891A0 (en) 2000-04-04 2001-03-30 Quinolinyl-piperidin 4-ylidene-methyl-benzamide derivatives for the treatment of pain
ES01918114T ES2236203T3 (es) 2000-04-04 2001-03-30 Derivados de quinolinil-piperidin-4-ilideno-metil-benzamida para el tratamiento del dolor.
US10/240,114 US6753335B2 (en) 2000-04-04 2001-03-30 Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain
EP01918114A EP1286986B1 (de) 2000-04-04 2001-03-30 Chinolinyl-piperidin-4-yliden-methyl-benzamid-derivate zur schmerzbekämpfung
RU2002125506/04A RU2002125506A (ru) 2000-04-04 2001-03-30 Хинолинил-пиперидин-4-илиден-метил-бензамидные производные для лечения боли
JP2001572496A JP2003529598A (ja) 2000-04-04 2001-03-30 疼痛の治療のためのキノリニルピペリジン−４−イリデン−メチルベンズアミド誘導体
CNB018104231A CN1182134C (zh) 2000-04-04 2001-03-30 用于治疗疼痛的喹啉基-亚哌啶-4-基-甲基-苯甲酰胺衍生物
DK01918114T DK1286986T3 (da) 2000-04-04 2001-03-30 Quinolinylpiperidin-4-ylidenmethylbenzamidderivater til behandling af smerte
AT01918114T ATE289603T1 (de) 2000-04-04 2001-03-30 Chinolinyl-piperidin-4-yliden-methyl-benzamid- derivate zur schmerzbekämpfung
PCT/SE2001/000708 WO2001074806A1 (en) 2000-04-04 2001-03-30 Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain
DE60109032T DE60109032T2 (de) 2000-04-04 2001-03-30 Chinolinyl-piperidin-4-yliden-methyl-benzamid-derivate zur schmerzbekämpfung
MXPA02009759A MXPA02009759A (es) 2000-04-04 2001-03-30 Derivados de quinolinil-piperidin-4-ilden-metil-benzamida para el tratamiento del dolor.
KR1020027013208A KR100755153B1 (ko) 2000-04-04 2001-03-30 동통 치료용 퀴놀리닐-피페리딘-4-일리덴-메틸-벤즈아미드유도체
IS6574A IS6574A (is) 2000-04-04 2002-09-30 Kínólinýl-píperidín-4-ýlíden-metýl-bensamíðafleiður til að meðhöndla sársauka
ZA200207973A ZA200207973B (en) 2000-04-04 2002-10-03 Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain.
NO20024777A NO323466B1 (no) 2000-04-04 2002-10-03 Nye kinolinyl-piperidin-4-yliden-metyl-benzamidderivater, fremgangsmate til fremstilling derav, anvendelse derav i medikamenter til behandling av smerte, samt farmasoytisk sammensetning som innbefatter slike derivater
HK03104019A HK1051692A1 (en) 2000-04-04 2003-06-06 Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0001208A SE0001208D0 (sv) 2000-04-04 2000-04-04 Novel compounds

Publications (1)

Publication Number Publication Date
SE0001208D0 true SE0001208D0 (sv) 2000-04-04

Family

ID=20279147

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0001208A SE0001208D0 (sv) 2000-04-04 2000-04-04 Novel compounds

Country Status (28)

Country Link
US (1) US6753335B2 (de)
EP (1) EP1286986B1 (de)
JP (1) JP2003529598A (de)
KR (1) KR100755153B1 (de)
CN (1) CN1182134C (de)
AR (1) AR029823A1 (de)
AT (1) ATE289603T1 (de)
AU (2) AU2001244982B2 (de)
BR (1) BR0109817A (de)
CA (1) CA2403600A1 (de)
CZ (1) CZ20023288A3 (de)
DE (1) DE60109032T2 (de)
EE (1) EE200200577A (de)
ES (1) ES2236203T3 (de)
HK (1) HK1051692A1 (de)
HU (1) HUP0300402A3 (de)
IL (1) IL151891A0 (de)
IS (1) IS6574A (de)
MX (1) MXPA02009759A (de)
NO (1) NO323466B1 (de)
NZ (1) NZ522143A (de)
PL (1) PL357770A1 (de)
PT (1) PT1286986E (de)
RU (1) RU2002125506A (de)
SE (1) SE0001208D0 (de)
SK (1) SK285076B6 (de)
WO (1) WO2001074806A1 (de)
ZA (1) ZA200207973B (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW548271B (en) 1996-12-20 2003-08-21 Astra Pharma Inc Novel piperidine derivatives having an exocyclic double bond with analgesic effects
SE0101765D0 (sv) 2001-05-18 2001-05-18 Astrazeneca Ab Novel compounds
SE0101766D0 (sv) 2001-05-18 2001-05-18 Astrazeneca Ab Novel compounds
SE0101768D0 (sv) * 2001-05-18 2001-05-18 Astrazeneca Ab Novel compounds
SE0103313D0 (sv) 2001-10-03 2001-10-03 Astrazeneca Ab Novel compounds
AU2003214800A1 (en) 2002-01-02 2003-07-24 Ardent Pharmaceuticals, Inc. Method of treating sexual dysfunctions with delta opioid receptor agonist compounds
KR20060010811A (ko) * 2003-05-16 2006-02-02 아스트라제네카 아베 디아릴메틸리덴 피페리딘 유도체, 그의 제조 및 그의 용도
SE0301442D0 (sv) * 2003-05-16 2003-05-16 Astrazeneca Ab Diarylmethylidene piperidine derivatives, preparations therof and uses thereof
SE0301441D0 (sv) * 2003-05-16 2003-05-16 Astrazeneca Ab Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof
CN1890208A (zh) 2003-12-12 2007-01-03 伊莱利利公司 类鸦片受体拮抗剂
SE0400026D0 (sv) * 2004-01-09 2004-01-09 Astrazeneca Ab Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof
SE0402485D0 (sv) 2004-10-13 2004-10-13 Astrazeneca Ab Polymorph of N,N-Diethyl-4-(3-Fluorophenyl-Piperidin-4-Ylidene-Methyl)-Benzamide Hydrochloride salt
MY148880A (en) * 2006-10-20 2013-06-14 Astrazeneca Ab N-(2-hydroxyethyl)-n-methyl-4-(quinolin-8-yl(1-(thiazol-4-ylmethyl)piperidin-4-ylidene)methyl)benzamide, the process of making it as well as its use for the treatment of pain, anxiety and depression

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2898339A (en) 1957-07-29 1959-08-04 Wm S Merrell Co N-substituted benzhydrol, benzhydryl, and benzhydrylidene piperidine
US4581171A (en) 1983-07-27 1986-04-08 Janssen Pharmaceutica, N.V. [[Bis(aryl)methylene]-1-piperidinyl]alkyl-pyrimidinones useful for treating psychotropic disorders
US4816586A (en) 1987-07-29 1989-03-28 Regents Of The University Of Minnesota Delta opioid receptor antagonists
US5140029A (en) 1989-01-09 1992-08-18 Janssen Pharmaceutica N.V. 2-aminopyrimidinone derivatives
US4939137A (en) 1989-06-28 1990-07-03 Ortho Pharmaceutical Corporation Ring-fused thienopyrimidinedione derivatives
US5683998A (en) 1991-04-23 1997-11-04 Toray Industries, Inc. Tricyclic triazolo derivatives, processes for producing the same and the uses of the same
US5574159A (en) 1992-02-03 1996-11-12 Delta Pharmaceuticals, Inc. Opioid compounds and methods for making therefor
GB9202238D0 (en) 1992-02-03 1992-03-18 Wellcome Found Compounds
SE9504661D0 (sv) 1995-12-22 1995-12-22 Astra Pharma Inc New compounds
TW548271B (en) * 1996-12-20 2003-08-21 Astra Pharma Inc Novel piperidine derivatives having an exocyclic double bond with analgesic effects
AU2009799A (en) * 1997-12-24 1999-07-19 Ortho-Mcneil Pharmaceutical, Inc. 4-(aryl(piperidin-4-yl)) aminobenzamides which bind to the delta-opioid receptor

Also Published As

Publication number Publication date
PT1286986E (pt) 2005-05-31
EP1286986B1 (de) 2005-02-23
CN1432012A (zh) 2003-07-23
NZ522143A (en) 2004-06-25
SK14242002A3 (sk) 2003-06-03
EP1286986A1 (de) 2003-03-05
HUP0300402A3 (en) 2005-07-28
DE60109032D1 (de) 2005-03-31
MXPA02009759A (es) 2003-05-27
SK285076B6 (sk) 2006-05-04
ES2236203T3 (es) 2005-07-16
KR20020084286A (ko) 2002-11-04
JP2003529598A (ja) 2003-10-07
HK1051692A1 (en) 2003-08-15
IS6574A (is) 2002-09-30
ZA200207973B (en) 2004-01-22
EE200200577A (et) 2004-06-15
US20030199548A1 (en) 2003-10-23
AU2001244982B2 (en) 2005-11-24
DE60109032T2 (de) 2006-04-06
HUP0300402A2 (hu) 2003-06-28
RU2002125506A (ru) 2004-04-10
NO20024777D0 (no) 2002-10-03
WO2001074806A1 (en) 2001-10-11
CN1182134C (zh) 2004-12-29
AU4498201A (en) 2001-10-15
PL357770A1 (en) 2004-07-26
CA2403600A1 (en) 2001-10-11
AR029823A1 (es) 2003-07-16
NO323466B1 (no) 2007-05-21
NO20024777L (no) 2002-12-03
CZ20023288A3 (cs) 2003-03-12
IL151891A0 (en) 2003-04-10
KR100755153B1 (ko) 2007-09-04
US6753335B2 (en) 2004-06-22
BR0109817A (pt) 2003-01-21
ATE289603T1 (de) 2005-03-15

Similar Documents

Publication Publication Date Title
SE0001207D0 (sv) Novel compounds
MXPA03010445A (es) Derivados de 4(fenil-piperazinil-metil) benzamida y su uso para tratamiento del dolor, ansiedad o trastornos gastrointestinales.
SE0103313D0 (sv) Novel compounds
SE0001208D0 (sv) Novel compounds
MXPA03010439A (es) Derivados de 4-(fenil-piperidin-a-iliden-metil)-benzamida y su uso para tratar dolor, ansiedad o trastornos gastrointestinales.
PT1242402E (pt) Novos compostos
SE0001209D0 (sv) Novel compounds
SE0101766D0 (sv) Novel compounds
BG106807A (en) Novel compounds
SE0101768D0 (sv) Novel compounds
SE0101767D0 (sv) Novel compounds
SE0101771D0 (sv) Novel compounds
SE0101769D0 (sv) Novel compounds
SE0101770D0 (sv) Novel compounds
SE0101773D0 (sv) Novel compounds
SE0101772D0 (sv) Novel compounds
TH61591A (th) อนุพันธ์ไฮดรอกซีเฟนิล-พิเพอราซินิลเมทิล-เบนซาไมด์สำหรับรักษาความเจ็บปวด